Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae
出版年份 2018 全文链接
标题
Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae
作者
关键词
-
出版物
CLINICAL MICROBIOLOGY REVIEWS
Volume 31, Issue 2, Pages e00079-17
出版商
American Society for Microbiology
发表日期
2018-02-13
DOI
10.1128/cmr.00079-17
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection
- (2018) Maddalena Giannella et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients: risk factors and predictors of mortality
- (2017) M. Papadimitriou-Olivgeris et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Activity of the novel siderophore cephalosporin cefiderocol against multidrug-resistant Gram-negative pathogens
- (2017) J. Dobias et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Double-carbapenem combination as salvage therapy for untreatable infections by KPC-2-producing Klebsiella pneumoniae
- (2017) M. Souli et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in Belgium from September to November 2015
- (2017) Te Din Huang et al. Eurosurveillance
- Aminoglycosides against carbapenem-resistant Enterobacteriaceae in the critically ill: the pitfalls of aminoglycoside susceptibility
- (2017) Alexandre P. Zavascki et al. Expert Review of Anti-Infective Therapy
- Trimethoprim–sulfamethoxazole therapy for patients with carbapenemase-producing Klebsiella pneumoniae infections: retrospective single-center case series
- (2017) Rita Murri et al. INFECTION
- Colistin versus polymyxin B for the treatment of patients with multidrug-resistant Gram-negative infections: a systematic review and meta-analysis
- (2017) Konstantinos Z. Vardakas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Susceptibility to cephalosporin combinations and aztreonam/avibactam among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission
- (2017) Alexander Mischnik et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Treating complicated carbapenem-resistant enterobacteriaceae infections with ceftazidime/avibactam: a retrospective study with molecular strain characterisation
- (2017) Fiorella Krapp et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes
- (2017) Rajnikant Sharma et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro antibacterial activity of fosfomycin combined with other antimicrobials against KPC-producing Klebsiella pneumoniae
- (2017) Wei Yu et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Role of piperacillin/tazobactam as a carbapenem-sparing antibiotic for treatment of acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli
- (2017) Young Kyung Yoon et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Clinical efficacy of ceftazidime/avibactam versus other active agents for the treatment of bacteremia due to carbapenemase-producing Enterobacteriaceae in hematologic patients
- (2017) Juan J. Castón et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Emergence of ceftazidime/avibactam non-susceptibility in an MDR Klebsiella pneumoniae isolate
- (2017) Anna Both et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value
- (2017) A. Oliva et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacodynamics of colistin and fosfomycin: a ‘treasure trove’ combination combats KPC-producing Klebsiella pneumoniae
- (2017) Miao Zhao et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals
- (2017) Matthew E. Falagas et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Increased activity of colistin in combination with amikacin against Escherichia coli co-producing NDM-5 and MCR-1
- (2017) Yu-Feng Zhou et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia–Pacific countries: SMART 2013–2015
- (2017) James A. Karlowsky et al. JOURNAL OF MEDICAL MICROBIOLOGY
- The plasmid-mediated fosfomycin resistance determinants and synergy of fosfomycin and meropenem in carbapenem-resistant Klebsiella pneumoniae isolates in Taiwan
- (2017) Sung-Pin Tseng et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
- (2017) Belén Gutiérrez-Gutiérrez et al. LANCET INFECTIOUS DISEASES
- Clinical and Bacterial Risk Factors for Mortality in Children With Carbapenem-resistant Enterobacteriaceae Bloodstream Infections in India
- (2017) Laura E. B. Nabarro et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Evaluation of Amikacin Pharmacokinetics and Pharmacodynamics for Optimal Initial Dosing Regimen
- (2017) Hideo Kato et al. Drugs in research & development
- The efficacy and safety of tigecycline for the treatment of bloodstream infections: a systematic review and meta-analysis
- (2017) Jian Wang et al. Annals of Clinical Microbiology and Antimicrobials
- In vitro Pharmacokinetics/Pharmacodynamics Evaluation of Fosfomycin Combined with Amikacin or Colistin against KPC2-Producing Klebsiella pneumoniae
- (2017) Wei Yu et al. Frontiers in Cellular and Infection Microbiology
- Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial
- (2017) Joseph Solomkin et al. JAMA Surgery
- Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China
- (2017) Rong Zhang et al. EBioMedicine
- Emergence of Ceftazidime-Avibactam Resistance and Restoration of Carbapenem Susceptibility in Klebsiella pneumoniae Carbapenemase-Producing K pneumoniae: A Case Report and Review of Literature
- (2017) Ryan K. Shields et al. Open Forum Infectious Diseases
- Bloodstream infections caused byKlebsiella pneumoniaein onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey
- (2016) Enrico Maria Trecarichi et al. AMERICAN JOURNAL OF HEMATOLOGY
- Modeling Meropenem Treatment, Alone and in Combination with Daptomycin, for KPC-Producing Klebsiella pneumoniae Strains with Unusually Low Carbapenem MICs
- (2016) P. Gagetti et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Combination Regimens for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections
- (2016) A. Gomez-Simmonds et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Stability of Novel Siderophore Cephalosporin S-649266 against Clinically Relevant Carbapenemases
- (2016) Tsukasa Ito-Horiyama et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamic Evaluation of the Potential Clinical Utility of Fosfomycin and Meropenem in Combination Therapy against KPC-2-Producing Klebsiella pneumoniae
- (2016) James Albiero et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumannii
- (2016) David M. Livermore et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of the β-Lactamase Inhibitor Vaborbactam Combined with Meropenem against Serine Carbapenemase-Producing Enterobacteriaceae
- (2016) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Plazomicin activity against 346 Extended-Spectrum-β-lactamase/AmpC-producing Escherichia coli urinary isolates, related to aminoglycoside-modifying enzymes characterized.
- (2016) Maria del Carmen López-Diaz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Association between the Presence of Aminoglycoside-Modifying Enzymes andIn VitroActivity of Gentamicin, Tobramycin, Amikacin, and Plazomicin against Klebsiella pneumoniae Carbapenemase- and Extended-Spectrum-β-Lactamase-Producing Enterobacter Species
- (2016) Ghady Haidar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Coexistence ofmcr-1andblaNDM-1in Escherichia coli from Venezuela
- (2016) Jose F. Delgado-Blas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- mcr-1.2, a NewmcrVariant Carried on a Transferable Plasmid from a Colistin-Resistant KPC Carbapenemase-Producing Klebsiella pneumoniae Strain of Sequence Type 512
- (2016) Vincenzo Di Pilato et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae
- (2016) Belén Gutiérrez-Gutiérrez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Global Dissemination ofblaKPCinto Bacterial Species beyond Klebsiella pneumoniae andIn VitroSusceptibility to Ceftazidime-Avibactam and Aztreonam-Avibactam
- (2016) Krystyna M. Kazmierczak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftazidime-avibactam as salvage therapy for infections caused by carbapenem-resistant organisms: a case series from the compassionate-use program
- (2016) Elizabeth Temkin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?
- (2016) Alexandre P. Zavascki et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne bla KPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections
- (2016) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Cefiderocol, a Parenteral Siderophore Cephalosporin, for Dose Adjustment Based on Renal Function
- (2016) Takayuki Katsube et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dosing and Pharmacokinetics of Polymyxin B in Patients with Renal Insufficiency
- (2016) Visanu Thamlikitkul et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome
- (2016) Claudia M. D. de Maio Carrilho et al. BMC INFECTIOUS DISEASES
- Cefmetazole for bacteremia caused by ESBL-producing enterobacteriaceae comparing with carbapenems
- (2016) Takahiko Fukuchi et al. BMC INFECTIOUS DISEASES
- Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program
- (2016) Florian M. Wagenlehner et al. CLINICAL INFECTIOUS DISEASES
- The Effectiveness and Safety of High-Dose Colistin: Prospective Cohort Study
- (2016) Yael Dishon Benattar et al. CLINICAL INFECTIOUS DISEASES
- Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality
- (2016) Laura J. Rojas et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program
- (2016) John E. Mazuski et al. CLINICAL INFECTIOUS DISEASES
- Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections: Table 1.
- (2016) Ryan K. Shields et al. CLINICAL INFECTIOUS DISEASES
- Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations
- (2016) David van Duin et al. CLINICAL INFECTIOUS DISEASES
- Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase–producing K. pneumoniae
- (2016) M. Falcone et al. CLINICAL MICROBIOLOGY AND INFECTION
- Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae
- (2016) A. Oliva et al. CLINICAL MICROBIOLOGY AND INFECTION
- Plasmid-mediated quinolone resistance: Two decades on
- (2016) José Manuel Rodríguez-Martínez et al. DRUG RESISTANCE UPDATES
- Treatment options for infections caused by carbapenem-resistantEnterobacteriaceae: can we apply “precision medicine” to antimicrobial chemotherapy?
- (2016) Federico Perez et al. EXPERT OPINION ON PHARMACOTHERAPY
- Aminoglycoside Resistance
- (2016) Yohei Doi et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Empirical third-generation cephalosporin therapy for adults with community-onset Enterobacteriaceae bacteraemia: Impact of revised CLSI breakpoints
- (2016) Chih-Chia Hsieh et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Carbapenemase-producing Klebsiella pneumoniae bloodstream infections in neutropenic patients with haematological malignancies or aplastic anaemia: Analysis of 50 cases
- (2016) Polydoros Tofas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Epidemiology and antimicrobial susceptibility profiles of pathogens causing urinary tract infections in the Asia-Pacific region: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2010–2013
- (2016) Shio-Shin Jean et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Susceptibility of contemporary isolates to fosfomycin: a systematic review of the literature
- (2016) Konstantinos Z. Vardakas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections
- (2016) Michael P. Veve et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro susceptibility of β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE) to eravacycline
- (2016) Yunliang Zhang et al. JOURNAL OF ANTIBIOTICS
- Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis
- (2016) Oren Zusman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of temocillin in a lethal murine model of infection of intra-abdominal origin due to KPC-producingEscherichia coli
- (2016) K. Alexandre et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitropharmacokinetics/pharmacodynamics of the combination of avibactam and aztreonam against MDR organisms
- (2016) Sherwin K. B. Sy et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A high-dose aminoglycoside regimen combined with renal replacement therapy for the treatment of MDR pathogens: a proof-of-concept study
- (2016) Alexandre Brasseur et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Evaluation of antibacterial activities of colistin, rifampicin and meropenem combinations against NDM-1-producingKlebsiella pneumoniaein 24 hin vitrotime–kill experiments
- (2016) P. Lagerbäck et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A pharmacokinetic–pharmacodynamic model characterizing the emergence of resistantEscherichia colisubpopulations during ertapenem exposure
- (2016) Wanchana Ungphakorn et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae : a pooled analysis of Phase 3 clinical trials
- (2016) Myra W. Popejoy et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study
- (2016) Belén Gutiérrez-Gutiérrez et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections
- (2016) Mohamad-Ali Trad et al. JOURNAL OF CHEMOTHERAPY
- Determination of synergy between sulbactam, meropenem and colistin in carbapenem-resistantKlebsiella pneumoniaeandAcinetobacter baumanniiisolates and correlation with the molecular mechanism of resistance
- (2016) Shakti Laishram et al. JOURNAL OF CHEMOTHERAPY
- Outbreaks of colistin-resistant and colistin-susceptible KPC-producing Klebsiella pneumoniae in a Brazilian intensive care unit
- (2016) I. Rossi Gonçalves et al. JOURNAL OF HOSPITAL INFECTION
- Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain
- (2016) Zaira R. Palacios-Baena et al. JOURNAL OF INFECTION
- Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study
- (2016) Yehuda Carmeli et al. LANCET INFECTIOUS DISEASES
- Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
- (2016) Yi-Yun Liu et al. LANCET INFECTIOUS DISEASES
- A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae
- (2016) Belén Gutiérrez-Gutiérrez et al. MAYO CLINIC PROCEEDINGS
- Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections
- (2016) Wentao Ni et al. MEDICINE
- Characterization of ST258 Colistin-Resistant,blaKPC-ProducingKlebsiella pneumoniaein a Greek Hospital
- (2016) Angeliki Mavroidi et al. Microbial Drug Resistance
- Clinical Characteristics of Carbapenem-resistant Klebsiella pneumoniae Infections in Ill and Colonized Children in Colombia
- (2016) Alejandro Díaz et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Treatment efficacy and superinfection rates in complicated urinarytract infections treated with ertapenem or piperacillin tazobactam
- (2016) Murat DİZBAY et al. Turkish Journal Of Medical Sciences
- Colistin- and Carbapenem-Resistant Escherichia coli Harboring mcr-1 and bla NDM-5 , Causing a Complicated Urinary Tract Infection in a Patient from the United States: TABLE 1
- (2016) José R. Mediavilla et al. mBio
- Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol
- (2016) Yaakov Dickstein et al. BMJ Open
- Tigecycline-Amikacin Combination Effectively Suppresses the Selection of Resistance in Clinical Isolates of KPC-Producing Klebsiella pneumoniae
- (2016) Wentao Ni et al. Frontiers in Microbiology
- Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods
- (2016) Chang-Ro Lee et al. Frontiers in Microbiology
- Impact of a high loading dose of amikacin in patients with severe sepsis or septic shock
- (2016) Nicolas Allou et al. Annals of Intensive Care
- Efficacy and Safety of a Colistin Loading Dose, High-Dose Maintenance Regimen in Critically Ill Patients With Multidrug-Resistant Gram-Negative Pneumonia
- (2016) Jessica L. Elefritz et al. JOURNAL OF INTENSIVE CARE MEDICINE
- Cefepime Therapy for Cefepime-Susceptible Extended-Spectrum β-Lactamase-ProducingEnterobacteriaceaeBacteremia: Table 1.
- (2016) Ruibin Wang et al. Open Forum Infectious Diseases
- Characterization and Clinical Impact of Bloodstream Infection Caused by Carbapenemase-Producing Enterobacteriaceae in Seven Latin American Countries
- (2016) Maria Virginia Villegas et al. PLoS One
- Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae
- (2016) Tat Ming Ng et al. PLoS One
- Combination Therapy against Polymicrobial Infection, Including by NDM-1-Producing Enterobacteriaceae Resistant to Colistin
- (2015) Itaru Nakamura et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Outcomes Associated with Polymyxin B Dose in Patients with Bloodstream Infections Due to Carbapenem-Resistant Gram-Negative Rods
- (2015) Brian C. Nelson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Optimizing the Initial Amikacin Dosage in Adults
- (2015) Bryan P. White et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Influence of Colistin Dose on Global Cure in Patients with Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacilli
- (2015) Gabrielle A. Gibson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Exploration of the Pharmacokinetic-Pharmacodynamic Relationships for Fosfomycin Efficacy Using anIn VitroInfection Model
- (2015) Brian D. VanScoy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cefepime Therapy for Monomicrobial Enterobacter cloacae Bacteremia: Unfavorable Outcomes in Patients Infected by Cefepime-Susceptible Dose-Dependent Isolates
- (2015) Nan-Yao Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics of Fosfomycin: Insights into Clinical Use for Antimicrobial Resistance
- (2015) F. Docobo-Pérez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients
- (2015) Ilias Karaiskos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Imipenem with Relebactam against Gram-Negative Pathogens from New York City
- (2015) Amabel Lapuebla et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of Aztreonam-Avibactam against a Global Collection of Gram-Negative Pathogens from 2012 and 2013
- (2015) Douglas J. Biedenbach et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Retrospective Study of Cefmetazole and Flomoxef for Treatment of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Bacteremia
- (2015) Yasufumi Matsumura et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivities of Ceftazidime-Avibactam, Aztreonam-Avibactam, and a Panel of Older and Contemporary Antimicrobial Agents against Carbapenemase-Producing Gram-Negative Bacilli
- (2015) Shawn Vasoo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Characterization of Carbapenem-Nonsusceptible Enterobacterial Isolates Collected during a Prospective Interregional Survey in France and Susceptibility to the Novel Ceftazidime-Avibactam and Aztreonam-Avibactam Combinations
- (2015) Hervé Dupont et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae
- (2015) Jessica B. Cprek et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance
- (2015) Johann D. D. Pitout et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroAntimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains
- (2015) Naoki Kohira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin-associated Acute Kidney Injury in Severely Ill Patients: A Step Toward a Better Renal Care? A Prospective Cohort Study
- (2015) Lidia Dalfino et al. CLINICAL INFECTIOUS DISEASES
- Carbapenem Therapy Is Associated With Improved Survival Compared With Piperacillin-Tazobactam for Patients With Extended-Spectrum -Lactamase Bacteremia
- (2015) P. D. Tamma et al. CLINICAL INFECTIOUS DISEASES
- In vitro susceptibilities of clinical isolates of carbapenemase-producing Enterobacteriaceae to fosfomycin and tigecycline
- (2015) S. Choudhury et al. CLINICAL MICROBIOLOGY AND INFECTION
- Treatment of KPC-producing Enterobacteriaceae: suboptimal efficacy of polymyxins
- (2015) M.S. de Oliveira et al. CLINICAL MICROBIOLOGY AND INFECTION
- Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case–control–control study
- (2015) D.R. Giacobbe et al. CLINICAL MICROBIOLOGY AND INFECTION
- Association Between Colistin Dose and Development of Nephrotoxicity*
- (2015) Yu-Ji Lee et al. CRITICAL CARE MEDICINE
- Antimicrobial treatment and outcomes of critically ill patients with OXA-48like carbapenemase-producing Enterobacteriaceae infections
- (2015) Warren Lowman et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases
- (2015) Krisztina M. Papp-Wallace et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- An outbreak of colistin-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in the Netherlands (July to December 2013), with inter-institutional spread
- (2015) V. Weterings et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains
- (2015) Iciar Rodríguez-Avial et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The combination of colistin and fosfomycin is synergistic against NDM-1-producing Enterobacteriaceae in in vitro pharmacokinetic/pharmacodynamic model experiments
- (2015) Mahableshwar S. Albur et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Comparative effectiveness of flomoxef versus carbapenems in the treatment of bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae with emphasis on minimum inhibitory concentration of flomoxef: a retrospective study
- (2015) Chen-Hsiang Lee et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- High-dose tigecycline-associated alterations in coagulation parameters in critically ill patients with severe infections
- (2015) Christina Routsi et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Efficacy and safety of tigecycline for the treatment of severe infectious diseases: an updated meta-analysis of RCTs
- (2015) Fengcai Shen et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Cefepime combined with amoxicillin/clavulanic acid: a new choice for the KPC-producing K. pneumoniae infection
- (2015) Shujuan Ji et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Therapeutic strategy for pandrug-resistant Klebsiella pneumoniae severe infections: short-course treatment with colistin increases the in vivo and in vitro activity of double carbapenem regimen
- (2015) Alessandra Oliva et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Synergistic killing of NDM-producing MDRKlebsiella pneumoniaeby two ‘old’ antibiotics—polymyxin B and chloramphenicol
- (2015) Nusaibah Abdul Rahim et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Mutagenesis of the CTX-M-type ESBL—is MIC-guided treatment according to the new EUCAST recommendations a safe approach?
- (2015) João M. Costa Ramos et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused byEnterobacter,CitrobacterorSerratiaspecies: a systematic review with meta-analysis
- (2015) Patrick N. A. Harris et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of temocillin in a murine model of urinary tract infection due toEscherichia coliproducing or not producing the ESBL CTX-M-15
- (2015) J. F. Soubirou et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study
- (2015) Mario Tumbarello et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Polymyxin B with dual carbapenem combination therapy against carbapenemase-producing Klebsiella pneumoniae
- (2015) Nathalie Grace Chua et al. JOURNAL OF INFECTION
- In vitro susceptibility of characterized β-lactamase-producing Gram-negative bacteria isolated in Japan to ceftazidime-, ceftaroline-, and aztreonam-avibactam combinations
- (2015) Ayumi Yoshizumi et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases
- (2015) Scott J. Hecker et al. JOURNAL OF MEDICINAL CHEMISTRY
- Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: A nationwide multicenter study in Taiwan
- (2015) Yea-Yuan Chang et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Extended-Spectrum β-Lactamase-ProducingEscherichia coliandKlebsiella pneumoniaeBacteremia in Febrile Neutropenic Children
- (2015) Seung Beom Han et al. Microbial Drug Resistance
- Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial
- (2015) Patrick NA Harris et al. Trials
- Safety and efficacy of colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia as part of a macro-project funded by the Seventh Framework Program of the European Commission studying off-patent antibiotics: study protocol for a randomized controlled trial
- (2015) Clara Rosso-Fernández et al. Trials
- High dose intravenous colistin methanesulfonate therapy is associated with high rates of nephrotoxicity; a prospective cohort study from Saudi Arabia
- (2015) Ali S Omrani et al. Annals of Clinical Microbiology and Antimicrobials
- Fosfomycin versus meropenem in bacteraemic urinary tract infections caused by extended-spectrum -lactamase-producing Escherichia coli (FOREST): study protocol for an investigator-driven randomised controlled trial
- (2015) C. Rosso-Fernandez et al. BMJ Open
- Assessment of combination therapy in BALB/c mice injected with carbapenem-resistant Enterobacteriaceae strains
- (2015) Noor A. Salloum et al. Frontiers in Microbiology
- Carbapenem-resistant Klebsiella pneumoniae infections in a Greek intensive care unit: Molecular characterisation and treatment challenges
- (2015) Maria Katsiari et al. Journal of Global Antimicrobial Resistance
- In vitro activities of colistin, tigecycline and tobramycin, alone or in combination, against carbapenem-resistant Enterobacteriaceae strains
- (2015) Berna Ozbek et al. Journal of Global Antimicrobial Resistance
- Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae
- (2015) Patrick N A Harris et al. Antimicrobial Resistance and Infection Control
- Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections
- (2015) H. J. Morrill et al. Open Forum Infectious Diseases
- Clinical Outcomes with Alternative Dosing Strategies for Piperacillin/Tazobactam: A Systematic Review and Meta-Analysis
- (2015) Hui Yang et al. PLoS One
- Three Dimensional Checkerboard Synergy Analysis of Colistin, Meropenem, Tigecycline against Multidrug-Resistant Clinical Klebsiella pneumonia Isolates
- (2015) Claudia Stein et al. PLoS One
- In VivoEfficacy of Humanized Exposures of Ceftazidime-Avibactam in Comparison with Ceftazidime against Contemporary Enterobacteriaceae Isolates
- (2014) Shawn H. MacVane et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroSusceptibility of Characterized β-Lactamase-Producing Strains Tested with Avibactam Combinations
- (2014) Henry Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Doripenem, Gentamicin, and Colistin, Alone and in Combinations, against Gentamicin-Susceptible, KPC-Producing Klebsiella pneumoniae Strains with VariousompK36Genotypes
- (2014) Cornelius J. Clancy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenem-Resistant Klebsiella pneumoniae Strains Exhibit Diversity in Aminoglycoside-Modifying Enzymes, Which Exert Differing Effects on Plazomicin and Other Agents
- (2014) Reem Almaghrabi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- UnexpectedIn VivoActivity of Ceftazidime Alone and in Combination with Avibactam against New Delhi Metallo-β-Lactamase-Producing Enterobacteriaceae in a Murine Thigh Infection Model
- (2014) Shawn H. MacVane et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Doripenem MICs andompK36Porin Genotypes of Sequence Type 258, KPC-Producing Klebsiella pneumoniae May Predict Responses to Carbapenem-Colistin Combination Therapy among Patients with Bacteremia
- (2014) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Double- and Triple-Antibiotic Combinations for VIM- and NDM-Producing Klebsiella pneumoniae byIn VitroTime-Kill Experiments
- (2014) T. Tängdén et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems
- (2014) George L. Daikos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of tigecycline, polymyxin, gentamicin, meropenem and associations in experimental Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae non-lethal sepsis
- (2014) Paula Virginia Michelon Toledo et al. Brazilian Journal of Infectious Diseases
- In vitro and in vivo activities of piperacillin-tazobactam and meropenem at different inoculum sizes of ESBL-producing Klebsiella pneumoniae
- (2014) Y. Harada et al. CLINICAL MICROBIOLOGY AND INFECTION
- Carbapenems and piperacillin/tazobactam for the treatment of bacteremia caused by extended-spectrum β-lactamase–producing Proteus mirabilis
- (2014) Hsih-Yeh Tsai et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Microbiological features of KPC-producing Enterobacter isolates identified in a U.S. hospital system
- (2014) Chulsoo Ahn et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Treatment of infections caused by carbapenemase-producing Enterobacteriaceae
- (2014) Jesús Rodríguez-Baño et al. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in cancer patients
- (2014) M. P. Freire et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Alternatives to carbapenems for infections caused by ESBL-producing Enterobacteriaceae
- (2014) B. Pilmis et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Successful control of a hospital-wide outbreak of OXA-48 producing Enterobacteriaceae in the Netherlands, 2009 to 2011
- (2014) M J Dautzenberg et al. Eurosurveillance
- Effectiveness and safety of high-dose tigecycline-containing regimens for the treatment of severe bacterial infections
- (2014) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Characterisation of the first ongoing outbreak due to KPC-3-producing Klebsiella pneumoniae (ST512) in Spain
- (2014) Lorena López-Cerero et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival
- (2014) Ilker Inanç Balkan et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Pharmacodynamic activity of ertapenem versus genotypically characterized extended-spectrum -lactamase (ESBL)-, KPC- or NDM-producing Escherichia coli with reduced susceptibility or resistance to ertapenem using an in vitro model
- (2014) G. G. Zhanel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- β-Lactam/β-lactamase inhibitors versus carbapenems for the treatment of sepsis: systematic review and meta-analysis of randomized controlled trials
- (2014) Shachaf Shiber et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administration
- (2014) P.-F. Laterre et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections
- (2014) A. Oliva et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Gentamicin therapy for sepsis due to carbapenem-resistant and colistin-resistant Klebsiella pneumoniae
- (2014) M. Gonzalez-Padilla et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Tigecycline in treatment of multidrug-resistant Gram-negative bacillus urinary tract infections: a systematic review
- (2014) K. Brust et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Impact of therapy and strain type on outcomes in urinary tract infections caused by carbapenem-resistant Klebsiella pneumoniae
- (2014) D. van Duin et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates
- (2014) P. Gaibani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Carbapenem Versus Fosfomycin Tromethanol in the Treatment of Extended-Spectrum Beta-Lactamase-ProducingEscherichia Coli-Related Complicated Lower Urinary Tract Infection
- (2014) S. Senol et al. JOURNAL OF CHEMOTHERAPY
- Evaluation of antimicrobial combinations against colistin-resistant carbapenemase (KPC)-producingKlebsiella pneumoniae
- (2014) S. Maraki et al. JOURNAL OF CHEMOTHERAPY
- Characterization of carbapenem resistance mechanisms inKlebsiella pneumoniaeandin vitrosynergy of the colistin–meropenem combination
- (2014) Lakshmana Gowda Krishnappa et al. JOURNAL OF CHEMOTHERAPY
- Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
- (2014) Thomas P Van Boeckel et al. LANCET INFECTIOUS DISEASES
- To B or Not to B, That Is the Question: Is It Time to Replace Colistin With Polymyxin B?
- (2014) Zahra Kassamali et al. PHARMACOTHERAPY
- Mutant prevention concentrations of ciprofloxacin against urinary isolates of Escherichia coli and Klebsiella pneumoniae
- (2014) Ziad Daoud et al. Journal of Infection in Developing Countries
- The inoculum effect of antibiotics against CTX-M-extended-spectrum β-lactamase-producing Escherichia coli
- (2014) Na Wu et al. Annals of Clinical Microbiology and Antimicrobials
- Inoculum Effect on the Efficacies of Amoxicillin-Clavulanate, Piperacillin-Tazobactam, and Imipenem against Extended-Spectrum β-Lactamase (ESBL)-Producing and Non-ESBL-Producing Escherichia coli in an Experimental Murine Sepsis Model
- (2013) F. Docobo-Pérez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of the MIC of Piperacillin-Tazobactam on the Outcome of Patients with Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Escherichia coli
- (2013) Pilar Retamar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characterization of Porin Expression in Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniae Identifies Isolates Most Susceptible to the Combination of Colistin and Carbapenems
- (2013) Jae H. Hong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Systematic Review and Meta-Analysis ofIn VitroSynergy of Polymyxins and Carbapenems
- (2013) Oren Zusman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivities of Ceftazidime-Avibactam and Aztreonam-Avibactam against 372 Gram-Negative Bacilli Collected in 2011 and 2012 from 11 Teaching Hospitals in China
- (2013) Xiaojuan Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Human Simulated Studies of Aztreonam and Aztreonam-Avibactam To Evaluate Activity against Challenging Gram-Negative Organisms, Including Metallo-β-Lactamase Producers
- (2013) Jared L. Crandon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Tigecycline in Combination with Colistin, Meropenem, Rifampin, or Gentamicin against KPC-Producing Enterobacteriaceae in a Murine Thigh Infection Model
- (2013) George Michail et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Humanized Carbapenem Exposures against New Delhi Metallo-β-Lactamase (NDM-1)-Producing Enterobacteriaceae in a Murine Infection Model
- (2013) Dora E. Wiskirchen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Humanized Carbapenem and Ceftazidime Regimens against Enterobacteriaceae Producing OXA-48 Carbapenemase in a Murine Infection Model
- (2013) Dora E. Wiskirchen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synergistic Activity of Colistin plus Rifampin against Colistin-Resistant KPC-Producing Klebsiella pneumoniae
- (2013) Carlo Tascini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibiotic Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae: Systematic Evaluation of the Available Evidence
- (2013) Matthew E. Falagas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens
- (2013) J. A. Sutcliffe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Randomized Phase 2 Trial To Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens versus Imipenem-Cilastatin for Treatment of Hospital-Acquired Pneumonia
- (2013) Julio Ramirez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Ertapenem use with Impact Assessment on Extended-Spectrum Beta-Lactamases (ESBL) Production and Gram-Negative resistance in Singapore General Hospital (SGH)
- (2013) Cheryl Li-Ling Lim et al. BMC INFECTIOUS DISEASES
- Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
- (2013) Emanuele Durante-Mangoni et al. CLINICAL INFECTIOUS DISEASES
- Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens
- (2013) Ana M. Sandri et al. CLINICAL INFECTIOUS DISEASES
- The Use of Cefepime for Treating AmpC β-Lactamase–Producing Enterobacteriaceae
- (2013) Pranita D. Tamma et al. CLINICAL INFECTIOUS DISEASES
- A disc diffusion assay for detection of class A, B and OXA-48 carbapenemases in Enterobacteriaceae using phenyl boronic acid, dipicolinic acid and temocillin
- (2013) K. van Dijk et al. CLINICAL MICROBIOLOGY AND INFECTION
- Evaluating amikacin dosage regimens in intensive care unit patients: A pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation
- (2013) Hinojal Zazo et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria
- (2013) Konstantinos Pontikis et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Emergence of an extensively drug-resistant ArmA- and KPC-2-producing ST101 Klebsiella pneumoniae clone in Italy
- (2013) M. L. Mezzatesta et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa
- (2013) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Impact of qnrA1, qnrB1 and qnrS1 on the efficacy of ciprofloxacin and levofloxacin in an experimental pneumonia model caused by Escherichia coli with or without the GyrA mutation Ser83Leu
- (2013) J. Dominguez-Herrera et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Risk factors and clinical characteristics of patients with qnr-positive Klebsiella pneumoniae bacteraemia
- (2013) C.-H. Liao et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy of doripenem and ertapenem against KPC-2-producing and non-KPC-producing Klebsiella pneumoniae with similar MICs
- (2013) M. Hagihara et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of temocillin against multidrug-resistant clinical isolates of Escherichia coli, Klebsiella spp. and Enterobacter spp., and evaluation of high-level temocillin resistance as a diagnostic marker for OXA-48 carbapenemase
- (2013) N. Woodford et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Carbapenem-resistantKlebsiella pneumoniaesepsis in corticosteroid receipt mice: tigecycline or colistin monotherapy versus tigecycline/colistin combination
- (2013) Hayati Demiraslan et al. JOURNAL OF CHEMOTHERAPY
- Activity of the colistin–rifampicin combination against colistin-resistant, carbapenemase-producing Gram-negative bacteria
- (2013) Marcela Nastro et al. JOURNAL OF CHEMOTHERAPY
- Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
- (2013) L Silvia Munoz-Price et al. LANCET INFECTIOUS DISEASES
- Tigecycline therapy for infections due to carbapenemase-producing Klebsiella pneumoniae in critically ill patients
- (2013) B. Balandin Moreno et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- KPC - 3 Klebsiella pneumoniaeST258 clone infection in postoperative abdominal surgery patients in an intensive care setting: analysis of a case series of 30 patients
- (2013) Paola Di Carlo et al. BMC Anesthesiology
- Carbapenem Therapy for Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Escherichia coli or Klebsiella pneumoniae: Implications of Ertapenem Susceptibility
- (2012) Nan-Yao Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens
- (2012) Zubair A. Qureshi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill
- (2012) Ami F. Mohamed et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Ertapenem for Treatment of Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae
- (2012) Vicki L. Collins et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Combination of Doripenem and Colistin Is Bactericidal and Synergistic against Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae
- (2012) Meredith G. Jernigan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Cefepime Therapy on Mortality among Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae and Escherichia coli
- (2012) Teena Chopra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Broad-Spectrum β-Lactam Antibiotics for Treating Experimental Peritonitis in Mice Due to Klebsiella pneumoniae Producing the Carbapenemase OXA-48
- (2012) Olivier Mimoz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Renal Disposition of Polymyxin B in an Animal Model
- (2012) Kamilia Abdelraouf et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of MK-7655, a Novel β-Lactamase Inhibitor, in Combination with Imipenem against Carbapenem-Resistant Gram-Negative Bacteria
- (2012) Elizabeth B. Hirsch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum beta-lactamase producing klebsiella pneumoniaein patients on maintenance hemodialysis
- (2012) Chih-Chao Yang et al. BMC INFECTIOUS DISEASES
- Epidemic of Klebsiella pneumoniae ST11 Clone Coproducing KPC-2 and 16S rRNA Methylase RmtB in a Chinese University Hospital
- (2012) Jun-Jie Li et al. BMC INFECTIOUS DISEASES
- Association Between Colistin Dose and Microbiologic Outcomes in Patients With Multidrug-Resistant Gram-Negative Bacteremia
- (2012) Giulia Vicari et al. CLINICAL INFECTIOUS DISEASES
- Cefepime Therapy for Monomicrobial Bacteremia Caused by Cefepime-Susceptible Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae: MIC Matters
- (2012) Nan-Yao Lee et al. CLINICAL INFECTIOUS DISEASES
- Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
- (2012) M. Tumbarello et al. CLINICAL INFECTIOUS DISEASES
- High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality
- (2012) A. Capone et al. CLINICAL MICROBIOLOGY AND INFECTION
- Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge
- (2012) C. Navarro-San Francisco et al. CLINICAL MICROBIOLOGY AND INFECTION
- Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions
- (2012) L. S. Tzouvelekis et al. CLINICAL MICROBIOLOGY REVIEWS
- Frequent detection of plasmid-mediated quinolone resistance (qnr) genes in multidrug-resistant Enterobacteriaceae blood isolates, Hong Kong
- (2012) C. C. Lee et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin
- (2012) George G Zhanel et al. Expert Review of Anti-Infective Therapy
- Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002–2010
- (2012) Chi-Chang Huang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The efficacy of cefmetazole against pyelonephritis caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae
- (2012) Asako Doi et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum -lactamases: a systematic review and meta-analysis
- (2012) K. Z. Vardakas et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence of resistance to fosfomycin used as adjunct therapy in KPC Klebsiella pneumoniae bacteraemia: report of three cases
- (2012) D. E. Karageorgopoulos et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Infections caused by OXA-48-producing Klebsiella pneumoniae in a tertiary hospital in Spain in the setting of a prolonged, hospital-wide outbreak
- (2012) J. R. Pano-Pardo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Impact of low-level fluoroquinolone resistance genes qnrA1, qnrB19 and qnrS1 on ciprofloxacin treatment of isogenic Escherichia coli strains in a murine urinary tract infection model
- (2012) L. Jakobsen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Assessment of Antimicrobial Combinations for Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae
- (2012) Elizabeth B. Hirsch et al. JOURNAL OF INFECTIOUS DISEASES
- Ertapénem intraveineux ou sous-cutané pour le traitement des infections urinaires à entérobactérie sécrétrice de BLSE
- (2012) E. Forestier et al. MEDECINE ET MALADIES INFECTIEUSES
- In VitroInteractions of Antimicrobial Combinations with Fosfomycin against KPC-2-Producing Klebsiella pneumoniae and Protection of Resistance Development
- (2011) Maria Souli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroPharmacodynamics of Simulated Pulmonary Exposures of Tigecycline Alone and in Combination againstKlebsiella pneumoniaeIsolates Producing a KPC Carbapenemase
- (2011) Dora E. Wiskirchen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae
- (2011) Catharine C. Bulik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Optimization of Aminoglycoside Therapy
- (2011) G. L. Drusano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
- (2011) S. M. Garonzik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative Effectiveness of Aminoglycosides, Polymyxin B, and Tigecycline for Clearance of Carbapenem-Resistant Klebsiella pneumoniae from Urine
- (2011) Michael J. Satlin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prospective, Non-Interventional, Multi-Centre Trial of Tigecycline in the Treatment of Severely Ill Patients with Complicated Infections – New Insights into Clinical Results and Treatment Practice
- (2011) Christian Eckmann et al. CHEMOTHERAPY
- -Lactam/ -Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum -Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts
- (2011) J. Rodriguez-Bano et al. CLINICAL INFECTIOUS DISEASES
- Can We Really Use ss-Lactam/ss-Lactam Inhibitor Combinations for the Treatment of Infections Caused by Extended-Spectrum ss-Lactamase-Producing Bacteria?
- (2011) F. Perez et al. CLINICAL INFECTIOUS DISEASES
- Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment
- (2011) O. Zarkotou et al. CLINICAL MICROBIOLOGY AND INFECTION
- Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?
- (2011) G.L. Daikos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli
- (2011) J. Rodríguez-Baño et al. CLINICAL MICROBIOLOGY AND INFECTION
- Colistin: new lessons on an old antibiotic
- (2011) D. Yahav et al. CLINICAL MICROBIOLOGY AND INFECTION
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Dosing of colistin—back to basic PK/PD
- (2011) Phillip J Bergen et al. CURRENT OPINION IN PHARMACOLOGY
- Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase–producing Escherichia coli or Klebsiella pneumoniae
- (2011) Nan-Yao Lee et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Detection of synergy using the combination of polymyxin B with either meropenem or rifampin against carbapenemase-producing Klebsiella pneumoniae
- (2011) George A. Pankey et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates
- (2011) G. Samonis et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Pharmacokinetic and pharmacodynamic evaluation of tigecycline
- (2011) Helen Giamarellou et al. Expert Opinion on Drug Metabolism & Toxicology
- Therapeutic options for infections withEnterobacteriaceaeproducing carbapenem-hydrolyzing enzymes
- (2011) Matthew E Falagas et al. Future Microbiology
- What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline
- (2011) David M. Livermore et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence
- (2011) David P. Nicolau et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae
- (2011) Z. Aktaş et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Ertapenem in the treatment of bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli: a propensity score analysis
- (2011) Un-In Wu et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Efficacy and safety of tigecycline: a systematic review and meta-analysis
- (2011) Dafna Yahav et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae
- (2011) B. Bercot et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens
- (2011) D. E. Karageorgopoulos et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and/or derepressed AmpC β-lactamase-producing Enterobacteriaceae
- (2011) Indran Balakrishnan et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis
- (2011) Efthimia Tasina et al. LANCET INFECTIOUS DISEASES
- Ertapenem for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing bacteria in children
- (2011) Nazan Dalgic et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Activities of NXL104 Combinations with Ceftazidime and Aztreonam against Carbapenemase-ProducingEnterobacteriaceae
- (2010) David M. Livermore et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Worldwide Experience with the Use of Doripenem against Extended-Spectrum- -Lactamase-Producing and Ciprofloxacin-Resistant Enterobacteriaceae: Analysis of Six Phase 3 Clinical Studies
- (2010) K. Kaniga et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Systematic Review and Meta-Analysis of the Effectiveness and Safety of Tigecycline for Treatment of Infectious Disease
- (2010) Yun Cai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroEffect ofqnrA1,qnrB1, andqnrS1Genes on Fluoroquinolone Activity against IsogenicEscherichia coliIsolates with Mutations ingyrAandparC
- (2010) A. Briales et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Ceftazidime and NXL104 in Two Murine Models of Infection Due to KPC-ProducingKlebsiella pneumoniae
- (2010) Andrea Endimiani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vivo Efficacy of Simulated Human Dosing Regimens of Prolonged-Infusion Doripenem against Carbapenemase- Producing Klebsiella pneumoniae
- (2010) C. C. Bulik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin Dosing and Nephrotoxicity in a Large Community Teaching Hospital
- (2010) C. A. DeRyke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bloodstream infections caused by qnr-positive Enterobacteriaceae: clinical and microbiologic characteristics and outcomes
- (2010) Yong Pil Chong et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin
- (2010) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Efficacy of carbapenems against a metallo- -lactamase-producing Escherichia coli clinical isolate in a rabbit intra-abdominal abscess model
- (2010) M. Souli et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates
- (2010) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ertapenem administered as outpatient parenteral antibiotic therapy for urinary tract infections caused by extended-spectrum- -lactamase-producing Gram-negative organisms
- (2010) R. Bazaz et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection
- (2010) Elizabeth B. Hirsch et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In Vitro Evaluation of Antibiotic Synergy for Polymyxin B-Resistant Carbapenemase-Producing Klebsiella pneumoniae
- (2010) A. Elemam et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Activity of Temocillin against KPC-Producing Klebsiella pneumoniae and Escherichia coli
- (2009) J. M. Adams-Haduch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Characteristics of Extended-Spectrum- -Lactamase-Producing Escherichia coli Isolates Causing Bacteremia in the Calgary Health Region from 2000 to 2007: Emergence of Clone ST131 as a Cause of Community-Acquired Infections
- (2009) J. D. D. Pitout et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Low-Level Resistance to Fluoroquinolones Due to qnrA1 and qnrS1 Genes or a gyrA Mutation on Ciprofloxacin Bactericidal Activity in a Murine Model of Escherichia coli Urinary Tract Infection
- (2009) N. Allou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Does the Activity of the Combination of Imipenem and Colistin In Vitro Exceed the Problem of Resistance in Metallo- -Lactamase-Producing Klebsiella pneumoniae Isolates?
- (2009) M. Souli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
- (2009) D. Plachouras et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of NXL104 in Combination with -Lactams against Klebsiella pneumoniae Isolates Producing KPC Carbapenemases
- (2009) A. Endimiani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum β-lactamase-producing and extended-spectrum β-lactamase-non-producing Escherichia coli isolates.
- (2009) L. López-Cerero et al. CLINICAL MICROBIOLOGY AND INFECTION
- AmpC -Lactamases
- (2009) G. A. Jacoby CLINICAL MICROBIOLOGY REVIEWS
- A review of tigecycline — the first glycylcycline
- (2009) Lance R. Peterson INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint
- (2009) Olaf Burkhardt et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Bacteraemia due to extended-spectrum -lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome
- (2009) C. Gudiol et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of the -lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases
- (2009) T. Stachyra et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens
- (2009) Garyphallia Poulakou et al. JOURNAL OF INFECTION
- Development of ertapenem resistance in a patient with mediastinitis caused by Klebsiella pneumoniae producing an extended-spectrum -lactamase
- (2009) D. Skurnik et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review
- (2009) Matthew E Falagas et al. LANCET INFECTIOUS DISEASES
- Community Infections Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli
- (2008) Jesús Rodríguez-Baño et al. ARCHIVES OF INTERNAL MEDICINE
- Breakpoints for extended-spectrum β-lactamase-producing Enterobacteriacae: pharmacokinetic/pharmacodynamic considerations
- (2008) A. MacGowan CLINICAL MICROBIOLOGY AND INFECTION
- Activity of ciprofloxacin and levofloxacin in experimental pneumonia caused by Klebsiella pneumoniae deficient in porins, expressing active efflux and producing QnrA1
- (2008) J.M. Rodríguez-Martínez et al. CLINICAL MICROBIOLOGY AND INFECTION
- Polymyxins Revisited
- (2008) D. Landman et al. CLINICAL MICROBIOLOGY REVIEWS
- Clinical significance of extended-spectrum β-lactamases
- (2008) Jesús Rodríguez-Baño et al. Expert Review of Anti-Infective Therapy
- Emergence of imipenem resistance in clinical Escherichia coli during therapy
- (2008) Jesús Oteo et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactam
- (2008) Johann D.D. Pitout et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae
- (2008) K. Vasilev et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum -lactamases and carbapenemases
- (2008) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
- (2008) Johann DD Pitout et al. LANCET INFECTIOUS DISEASES
- Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 β-lactamase–producing Klebsiella pneumoniae epidemic clone
- (2007) Javier Cobo et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started